The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Liposomal Delivery Systems: Design Optimization and Current Applications
Open accessAbstract
The liposome, a closed phospholipid bilayered vesicular system, has received considerable attention as a pharmaceutical carrier of great potential over the past 30 years. The ability of liposomes to encapsulate both hydrophilic and hydrophobic drugs, coupled with their biocompatibility and biodegradability, make liposomes attractive vehicles in the field of drug delivery. In addition, great technical advances such as remote drug loading, triggered release liposomes, ligand-targeted liposomes, liposomes containing combinations of drugs, and so on, have led to the widespread use of liposomes in diverse areas as delivery vehicles for anti-cancer, bio-active molecules, diagnostics, and therapeutic agents. In this review, we summarize design optimization of liposomal systems and invaluable applications of liposomes as effective delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,809
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Theranostics: Combining Imaging and Therapy
Kelkar, S. S., & Reineke, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200151q · Cited by 1,385
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizon, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,131
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Locoregional cancer treatment with magnetic drug targeting.
Alexiou, C., Arnold, W. J., Klein, R. J., Parak, F., Hulin, P., Bergemann, C., Erhardt, W. D., Wagenpfeil, S., & Lübbe, A. S. (2000) · PubMed · Cited by 863
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746
Large unilamellar liposomes with low uptake into the reticuloendothelial system
Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729
Al-Jamal, W. T., & Kostarelos, K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200105p · Cited by 696
Breaking down the barriers: siRNA delivery and endosome escape
Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630
Fate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 574
RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING
Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 543
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1664 · Cited by 499
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Serum-induced leakage of liposome contents
Allen, T. M., & Cleland, L. G. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90118-2 · Cited by 468
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 460
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
Laginha, K. M., Verwoert, S., Charrois, G. J. R., & Allen, T. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0343 · Cited by 441
Raposo, G., Tenza, D., Mecheri, S., Peronet, R., Bonnerot, C., & Desaymard, C. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.12.2631 · Cited by 406
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
Ta, T., & Porter, T. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.036 · Cited by 403
Allen, C., Dos Santos, N., Gallagher, R., Chiu, G. N. C., Shu, Y., Li, W. M., Johnstone, S. A., Janoff, A. S., Mayer, L. D., Webb, M. S., et al. (2002) · Bioscience Reports · doi:10.1023/a:1020186505848 · Cited by 388
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Self-assembling protein nanoparticles in the design of vaccines
López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.11.001 · Cited by 353
Powering membrane traffic in endocytosis and recycling
Soldati, T., & Schliwa, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2060 · Cited by 346
Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 345
The Mechanism of Vesicle Fusion as Revealed by Molecular Dynamics Simulations
Marrink, S. J., & Mark, A. E. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036138+ · Cited by 344
Thermosensitive liposomal drug delivery systems: state of the art review
Hossann, M., Kneidl, B., Peller, M., Lindner, L., & Winter, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s49297 · Cited by 342
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience
Adler-Moore, J., & Proffitt, R. T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.21 · Cited by 339
Legendre, J.-Y., & Szoka Jr, F. C. (1992) · Pharmaceutical Research · doi:10.1023/a:1015836829670 · Cited by 332
Gubernator, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566552 · Cited by 325
Molecular mechanism of the lipid vesicle longevity in vivo
Blume, G., & Cevc, G. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90351-y · Cited by 313
Ultrasound triggered release of cisplatin from liposomes in murine tumors
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305
Charrois, G. J. R., & Allen, T. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.006 · Cited by 300
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
Xing, H., Hwang, K., & Lu, Y. (2016) · Theranostics · doi:10.7150/thno.15464 · Cited by 296
pH-Sensitive liposomes-principle and application in cancer therapy
Karanth, H., & Murthy, R. S. R. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.4.0001 · Cited by 294
Forssen, E., & Willis, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00083-5 · Cited by 287
Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs
Alving, C. R., Steck, E. A., Chapman, W. L., Waits, V. B., Hendricks, L. D., Swartz, G. M., & Hanson, W. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2959 · Cited by 284
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients
Mayer, L. D., Tai, L. C. L., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S., & Cullis, P. R. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90091-2 · Cited by 245
Haluska, C. K., Riske, K. A., Marchi-Artzner, V., Lehn, J.-M., Lipowsky, R., & Dimova, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602766103 · Cited by 240
Nishikawa, K., Arai, H., & Inoue, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34110-9 · Cited by 232
Amphiphilic poly-N-vinylpyrrolidones:
Torchilin, V. P., Levchenko, T. S., Whiteman, K. R., Yaroslavov, A. A., Tsatsakis, A. M., Rizos, A. K., Michailova, E. V., & Shtilman, M. I. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00050-3 · Cited by 214
Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., & Li, S.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.029 · Cited by 213
Functionalized‐Quantum‐Dot–Liposome Hybrids as Multimodal Nanoparticles for Cancer
Al‐Jamal, W. T., Al‐Jamal, K. T., Bomans, P. H., Frederik, P. M., & Kostarelos, K. (2008) · Small · doi:10.1002/smll.200701043 · Cited by 199
Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, R. C., & Baldeschwieler, J. D. (1983) · Science · doi:10.1126/science.6836294 · Cited by 190
Zhigaltsev, I. V., Maurer, N., Akhong, Q.-F., Leone, R., Leng, E., Wang, J., Semple, S. C., & Cullis, P. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.010 · Cited by 186
Basha, G., Novobrantseva, T. I., Rosin, N., Tam, Y. Y. C., Hafez, I. M., Wong, M. K., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.190 · Cited by 181
Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo
Song, S., Liu, D., Peng, J., Sun, Y., Li, Z., Gu, J.-R., & Xu, Y. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.012 · Cited by 180
Tollemar, J., Höckerstedt, K., Ericzon, B.-G., Jalanko, H., & Ringdén, O. (1995) · Transplantation · doi:10.1097/00007890-199501150-00009 · Cited by 179
Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.
Herman, E., Rahman, A., Ferrans, V. J., Vick, J., & Schein, P. (1983) · PubMed · Cited by 179
Liposomal drug delivery systems--clinical applications.
Goyal, P., Goyal, K., Kumar, S. G. V., Singh, A., Katare, O. P., & Mishra, D. N. (2005) · PubMed · Cited by 178
A liposome-based nanostructure for aptamer directed delivery
Kang, H., O’Donoghue, M. B., Liu, H., & Tan, W. (2010) · Chem. Commun. · doi:10.1039/b916911c · Cited by 169
Remote loading of preencapsulated drugs into stealth liposomes
Sur, S., Fries, A. C., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324135111 · Cited by 169
Sonali, Singh, R. P., Singh, N., Sharma, G., Vijayakumar, M. R., Koch, B., Singh, S., Singh, U., Dash, D., Pandey, B. L., et al. (2016) · Drug Delivery · doi:10.3109/10717544.2016.1162878 · Cited by 159
Damen, J., Regts, J., & Scherphof, G. L. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90268-x · Cited by 155
Is half‐life of circulating liposomes determined by changes in their permeability?
Senior, J. H., & Gregoriadis, G. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81216-7 · Cited by 153
Saito, R., Krauze, M. T., Bringas, J. R., Noble, C. O., McKnight, T. R., Jackson, P., Wendland, M. F., Mamot, C., Drummond, D. C., Kirpotin, D. B., et al. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.016 · Cited by 150
Yang, S., Zaitseva, E., Chernomordik, L., & Melikov, K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.08.029 · Cited by 147
Ma, Y., Zhuang, Y., Xie, X., Wang, C., Wang, F., Zhou, D., Zeng, J., & Cai, L. (2011) · Nanoscale · doi:10.1039/c1nr10166h · Cited by 139
Cullis, P. R. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80762-4 · Cited by 139
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
van Hoesel, Q. G. C. M., Steerenberg, P. A., Crommelin, D. J. A., van Dijk, A., van Oort, W. J., Klein, S., Douze, J. M. C., Wildt, D. J. D., & Hillen, F. C. (1984) · PubMed · Cited by 120
Influence of dose on liposome clearance: critical role of blood proteins
Oja, C. D., Semple, S. C., Chonn, A., & Cullis, P. R. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00003-x · Cited by 119
Storm, G., Roerdink, F. H., Steerenberg, P. A., de Jong, W. H., & Crommelin, D. J. A. (1987) · PubMed · Cited by 112
Lozano, N., Al-Ahmady, Z. S., Bézière, N., Ntziachristos, V., & Kostarelos, K. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.045 · Cited by 111
Lila, A. S. A., Kizuki, S., Doi, Y., Suzuki, T., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.023 · Cited by 107
Self-citationPagnan, G., Stuart, D. D., Pastorino, F., Raffaghello, L., Montaldo, P. G., Allen, T. M., Calabretta, B., & Ponzoni, M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.253 · Cited by 106
Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel.
Cabanes, A., Briggs, K., Gokhale, P. C., Treat, J., & Rahman, A. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.5.1035 · Cited by 103
Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes
Zhu, L., Huo, Z., Wang, L., Tong, X., Xiao, Y. Z., & Ni, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.003 · Cited by 102
Guan, H. H., Budzynski, W. A., Koganty, R. R., Krantz, M. J., Reddish, M. A., Rogers, J. A., Longenecker, B. M., & Samuel, J. (1998) · Bioconjugate Chemistry · doi:10.1021/bc970183n · Cited by 96
Stuart, D. D., Kao, G. Y., & Allen, T. M. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700145 · Cited by 92
Immunoliposome Targeting to Mesangial Cells
Tuffin, G., Waelti, E. R., Huwyler, J., Hammer, C., & Marti, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050485 · Cited by 86
Paszko, E., & Senge, M. O. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803833362 · Cited by 84
Peng, Z., Wang, C., Fang, E., Lu, X., Wang, G., & Tong, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092924 · Cited by 82
Optimization of the retention properties of vincristine in liposomal systems
Boman, N. L., Mayer, L. D., & Cullis, P. R. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90256-y · Cited by 80
Pastorino, F., Brignole, C., Marimpietri, D., Pagnan, G., Morando, A., Ribatti, D., Semple, S. C., Gambini, C., Allen, T. M., & Ponzoni, M. (2003) · PubMed · Cited by 77
Xu, H., Hu, M., Xiu, Y., Li, Y., Fu, Y., Zhou, X., Zhang, D., & Li, J. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.030 · Cited by 76
Modi, S., Xiang, T., & Anderson, B. D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.001 · Cited by 74
In vitroandin vivoantitumoral activity of free, and encapsulated taxol
Bartoli, M. H., Boitard, M., Fessi, H., Bériel, H., Devissaguet, J. P., Picot, F., & Puisieux, F. (1990) · Journal of Microencapsulation · doi:10.3109/02652049009021832 · Cited by 68
Lila, A. S. A., Suzuki, T., Doi, Y., Ishida, T., & Kiwada, H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.018 · Cited by 66
Self-citationda Cruz, M. T. G., Simões, S., Pires, P., Nir, S., & de Lima, M. C. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00342-4 · Cited by 64
Wan, Y., Angleson, J. K., & Kutateladze, A. G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016874i · Cited by 63
Zhu, Q., Guo, T., Xia, D., Li, X., Zhu, C., Li, H., Ouyang, D., Zhang, J., & Gan, Y. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12074 · Cited by 60
Non‐Viral Vector as Vaccine Carrier
Chen, W. C., & Huang, L. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54013-6 · Cited by 55
Sachse, A., LEIKE, J. U., THOMAS SCHNEIDER, Wagner, S., RÖling, G. L., Kŕause, W., & Brandl, M. (1997) · Investigative Radiology · doi:10.1097/00004424-199701000-00007 · Cited by 53
Preparation and Evaluation of Lyophilized Iopromide-Carrying Liposomes for Liver Tumor Detection
Sachse, A., LEIKE, J. U., RÖling, G. L., Wagner, S. E., & Kŕause, W. (1993) · Investigative Radiology · doi:10.1097/00004424-199328090-00019 · Cited by 52
Nanobiotechnological Approaches to Delivery of DNA Vaccine Against Fungal Infection
Ribeiro, A. M., Souza, A. C. O., Amaral, A. C., Vasconcelos, N. ‐., Jerônimo, M. S., Carneiro, F. P., Faccioli, L. H., Felipe, M. S. S., Silva, C. L., & Bocca, A. L. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1491 · Cited by 47
Løkling, K., Fossheim, S. L., Klaveness, J., & Skurtveit, R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.015 · Cited by 47
MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies
Ren, L., Chen, S., Li, H., et al. (2015) · Nanoscale · doi:10.1039/c5nr02144h · Cited by 46
Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach
Ascenso, A., Cruz, M., Euletério, C., Carvalho, F. A., Santos, N. C., Cabral-Marques, H. M., & Simões, S. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2013.788026 · Cited by 46
Factors affecting the encapsulation of drugs within liposomes
Stamp, D., & Juliano, R. L. (1979) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y79-081 · Cited by 42
Intelligent Design of Multifunctional lipid-coated Nanoparticle Platforms for Cancer Therapy
Ramishetti, S., & Huang, L. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.127 · Cited by 42
Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy
Sharma, R. K., Mody, N., Agrawal, U., & Vyas, S. P. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160219122524 · Cited by 42
Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy
Wu, H., & Chang, D.-K. (2010) · Journal of Oncology · doi:10.1155/2010/723798 · Cited by 40
Kaul, A., Chaturvedi, S., Attri, A., Kalra, M., & Mishra, A. K. (2016) · RSC Advances · doi:10.1039/c6ra01135g · Cited by 40
Ando, H., Kobayashi, S., Lila, A. S. A., Eldin, N. E., Kato, C., Shimizu, T., Ukawa, M., Kawazoe, K., & Ishida, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.019 · Cited by 36
Self-citationLiposome disposition in vivo: effects of pre-dosing with lipsomes.
Abra, R. M., Bosworth, M. E., & Hunt, C. A. (1980) · PubMed · Cited by 36
Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA
Wilner, S. E., & Levy, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3197-2_18 · Cited by 28
Weissmann, G., Cohen, C., & Hoffstein, S. T. (1976) · PubMed · Cited by 4
Cited by
PEGylated liposomes: immunological responses
Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 523
Self-citationSurface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010195 · Cited by 509
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications
Deslouches, B., & Di, Y. P. (2017) · Oncotarget · doi:10.18632/oncotarget.16743 · Cited by 390
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Lee, M.-K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030264 · Cited by 335
Metadata
- Authors
- Abu Lila, A. S., & Ishida, T.
- Venue
- Biological & Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2017
- Volume
- 40
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0918-6158 (ISSN-L)
- 1347-5215
- OpenAlex
- W2564567560
- Cited by
- 382
- References
- 114
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.